MATN1 and central nervous system cancer: In addition, we further demonstrated that MATN1‐AS1 inhibition largely increased the expression of miR‐200b/c/429 (Figure 4F), whereas miR‐200b/c/429 overexpression declined MATN1‐AS1 expression in the two glioma cells (Figure 4G).